Diisopropylamine → HCID 10950195, compound
Reaction equation
C([Li])CCC.C(NC(C)C)(C)C.[NH:13]1[C:17]2[CH:18]=[CH:19][CH:20]=[CH:21][C:16]=2[N:15]=[C:14]1[CH2:22][CH2:23][CH2:24][N:25]([CH3:29])[C:26](=[O:28])[CH3:27].[F:30][C:31]1[CH:32]=[C:33]2[C:38](=[CH:39][CH:40]=1)[C@H:37]([CH:41]([CH3:43])[CH3:42])[C:36](=[O:44])[CH2:35][CH2:34]2>CCCCCC.O1CCCC1.C1(C)C=CC=CC=1.O.CCCCC>[NH:13]1[C:17]2[CH:18]=[CH:19][CH:20]=[CH:21][C:16]=2[N:15]=[C:14]1[CH2:22][CH2:23][CH2:24][N:25]([CH3:29])[C:26](=[O:28])[CH2:27][C@@:36]1([OH:44])[CH2:35][CH2:34][C:33]2[C:38](=[CH:39][CH:40]=[C:31]([F:30])[CH:32]=2)[C@@H:37]1[CH:41]([CH3:42])[CH3:43]Participants
Reactant 4
Product 1
Reagents, catalysts & solvents 5
Conditions
- Temperature
- 0 °C
Procedure
Under a dry nitrogen atmosphere, a 2.5 molar solution of butyllithium in hexane, 8.4 mL (21 mmol) was added by syringe to 20 mL pentane. The solution was cooled to 0° C. and 2.75 mL (2.13 g, 21 mmol) diisopropylamine was added by syringe over six minutes. The solution was warmed to 25° C. and stirred for three hours, then volatiles were removed in vacuo. Tetrahydrofuran, 20 mL, was added via syringe to the residue, and the resulting yellow solution cooled to 0° C. A solution of 2.42 g (10.5 mmol) N-[3-(1H-benzimidazol-2-yl)propyl]-N-methylacetamide in 10 mL tetrahydrofuran was added by syringe over nine minutes. The yellow solution was stirred at 0° C. for fifteen minutes, then cooled to -78° C. (S)-6-Fluoro-1-isopropyl-3,4-dihydro-1H-naphthalen-2-one, 2.166 g, 87.2% pure, 97.6:2.4 S:R, in 2 mL toluene was added by syringe over twelve minutes, and a further 2 mL toluene was used to complete the transfer. After stirring at -78° C. for two hours, the viscous yellow mixture was added to 50 mL water at less than 10° C. The suspension that formed was extracted with 50 mL diethyl ether, then with a further 25 mL diethyl ether; and the combined ether extracts were dried over anhydrous magnesium sulfate, filtered, and concentrated in vacuo to afford 3.74 g of impure (1S,2S)-N-[3-(1H-benzimidazol-2-yl)propyl]-2-(6-fluoro-2-hydroxy-1-isopropyl-1,2,3,4-tetrahydronaphthalen-2-yl)-N-methylacetamide as a yellow foam. The foam was recrystallized from 6-8 mL toluene, and washed on the filter with 5 mL of toluene at -30° C. to afford 2.69 g of (1S,2S)-N-[3-(1H-benzimidazol-2-yl)propyl]-2-(6-fluoro-2-hydroxy-1-isopropyl-1,2,3,4-tetrahydronaphthalen-2-yl)-N-methylacetamide as a colorless solid, m.p. 132°-138° C. This material may be recrystallized a second time from toluene to remove residual (S)-6-fluoro-1-isopropyl-3,4-dihydro-1H-naphthalen-2-one if necessary and desired.
Workup
- temperatureThe solution was warmed to 25° C.
- customvolatiles were removed in vacuo
- additionTetrahydrofuran, 20 mL, was added via syringe to the residue
- temperaturethe resulting yellow solution cooled to 0° C
- stirringThe yellow solution was stirred at 0° C. for fifteen minutes
- stirringAfter stirring at -78° C. for two hours
- customThe suspension that formed
- extractionwas extracted with 50 mL diethyl ether
- dry with materialand the combined ether extracts were dried over anhydrous magnesium sulfate
- filtrationfiltered
- concentrationconcentrated in vacuo
Sources & evidence
- ORD record
- ord-a84ad0474f7a45198a7021af62be0c29
- Source dataset
- uspto-grants-1998_09
- Patent number
- US05808088
Reaction notes
Loading…